Antiestrogenic effects of marijuana smoke condensate and cannabinoid compounds

Archives of Pharmacal Research

Volumn 28, Issue 12, 2005, Pages 1365-1375

  Lee, Soo Yeun ^a,b   Seung, Min Oh ^b   Sang, Ki Lee ^a   Kyu, Hyuck Chung ^b  

^a National Institute of Scientific Investigation   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Antiestrogenic effects; Cannabinoids; Drug abuse; Marijuana; Polycyclic aromatic hydrocarbons (PAHs)

Indexed keywords

EID: 29944444765     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977903     Document Type: Article

References (46)

1. Arcaro, K. F., O'Keefe, P. W., Yang, Y., Clayton, W., and Gierthy, J. F., Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology, 133, 115-127 (1999).
2. Ashton, C. H., Adverse effects of cannabis and cannabinoids: a review. Br. J. Anaesth., 83, 637-649 (1999).
3. Berstein, L. M., Tsyrlina, E. V., Krjukova, O. G., and Dzhumasultanova, S. V., Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett., 127, 95-98 (1998).
4. Bradford, M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
5. Bradlow, H. L., Telang, N. T., Sepkovic, D. W., and Osborne, M. P., 2-hydroxyestrone: the 'good' estrogen: a review. J. Endocrinol., 150, S259-S265 (1996).
6. Brown, T. T. and Dobs, A. S., Endocrine effects of marijuana: a review. J. Clin. Pharmacol., 42, 90S-96S (2002).
7. Chaloupka, K., Krishnan, V., and Safe, S., Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells: role of the Ah receptor. Carcinogenesis, 13, 2233-2239 (1992).
8. Chung, H., Park, M., Hahn, E., Choi, H., Choi, H., and Lim, M., Recent trends of drug abuse and drug-associated deaths in Korea. Ann. N. Y. Acad. Sci., 1025, 458-464 (2004).
9. Dannan, G. A., Porubek, D. J., Nelson, S. D., Waxman, D. J., and Guengerich, F.P., 17 Beta-estradiol 2- and 4-hydroxylation catalyzed by rat hepatic cytochrome P-450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement. Endocrinology, 118, 1952-1960 (1986).
10. Drenth, H. J., Bouwman, C. A., Seinen, W., and Van den Berg, M., Effects of some persistent halogenated environmental contaminants on aromatase (CYP19) activity in the human choriocarcinoma cell line JEG-3. Toxicol. Appl. Pharmacol., 148, 50-55 (1998).
11. Gross-Steinmeyer, K., Stapleton, P. L., Liu, F., Tracy, J. H., Bammler, T. K., Quigley, S. D., Farin, F. M., Buhler, D. R., Safe, S. H., Strom, S. C., and Eaton, D. L., Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. Xenobiotica, 34, 619-632 (2004).
12. Hasselberg, L., Meier, S., Svardal, A., Hegelund, T., and Celander, M. C., Effects of alkylphenols on CYP1A and CYP3A expression in first spawning Atlantic cod (Gadus morhua). Aquat. Toxicol., 67, 303-313 (2004).
13. Hummerich, J., Zohm, C., and Pfau, W., Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines. Toxicology, 199, 231-240 (2004).
14. Iba, M. M., Nguyen, T., and Fung, J., CYP1A1 induction by pyridine and its metabolites in HepG2 cells. Arch. Biochem. Biophys., 404, 326-334 (2002).
15. Kamiya, M., Toriba, A., Onoda, Y., Kizu, R., and Hayakawa, K., Evaluation of estrogenic activities of hydroxylated polycyclic aromatic hydrocarbons in cigarette smoke condensate. Food Chem. Toxicol., 43, 1017-1027 (2005).
16. Korach, K. S., Davis, V. L., Curtis, S. W., and Bocchinfuso, W. P., Xenoestrogens and estrogen receptor action, In Thomas, J. A., and Colby, H. D. (Eds.). Endocrine Toxicology. Talylor & Francis, pp. 181-205, (1997).
17. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton J. C., Safe S. H., Van Der Saag, P. T., Van Der Burg, B., and Gustafsson, J. A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263 (1998).
18. Lewtas, J., Chuang, J., Nishioka, M., and Peterson, B., Bioassay-directed fractionation of the organic extract of SRM 1649 urban air particulate matter. Int. J. Environ. Anal. Chem. 39, 245-256 (1990).
19. Martin, B. R., Cellular effects of cannabinoids. Pharmacol. Rev., 38, 45-74 (1986).
20. Meek, M. D. and Finch, G. L., Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ. Res., 80, 9-17 (1999).
21. Mueck, A. O. and Seeger, H., Smoking, estradiol metabolism and hormone replacement therapy. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 3, 45-54 (2005).
22. Nahas, G. and Latour, C., The human toxicity of marijuana: a review. Med. J. Aust., 156, 495-497 (1992).
23. Perez, P., Pulgar, R., Olea-Serrano, F., Villalobos, M., Rivas, A., Metzler, M., Pedraza, V., and Olea, N., The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ. Health. Perspect., 106, 167-174 (1998).
24. Porter, W. and Safe, S. H, Estrogenic and antiestrogenic compounds, In Puga, A., and Wallace, K. B. (Eds.). Molecular biology of the toxic response. Talylor & Francis, pp. 267-279, (1999).
25. Rawitch, A. B., Schultz, G. S., Ebner, K. E., and Vardaris, R. M., Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science, 197, 1189-1191 (1977).
26. Robert, M. J., A primer of drug action. Fifth Edition. W. H. Freeman and Company, New York, (1988).
27. Rosenkrantz, H. and Esber, H. J., Cannabinoid-induced hormone changes in monkeys and rats. J. Toxicol. Environ. Health., 6, 297-313 (1980).
28. Roth, M. D., Marques-Magallanes, J. A., Yuan, M., Sun, W., Tashkin, D. P., and Hankinson, O., Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am. J. Respir. Cell Mol. Biol., 24, 339-344 (2001).
29. Ruh, M. F., Taylor, J. A., Howlett, A. C., and Welshons, W. V., Failure of cannabinoid compounds to stimulate estrogen receptors. Biochem. Pharmacol., 53, 35-41 (1997).
30. Safe, S. and Wormke, M., Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action: a review. Chem. Res. Toxicol., 16, 807-816 (2003).
31. Sauer, M. A., Rifka, S. M., Hawks, R. L., Cutler, G.. B. Jr., and Loriaux, D. L., Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther., 224, 404-407 (1983).
32. Schneider, J., Huh, M.M., Bradlow, H. L., and Fishman, J., Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259, 4840-4845 (1984).
33. Shou, M., Korzekwa, K. R., Brooks, E. N., Krausz, K. W., Gonzalez, F. J., and Gelboin, H. V., Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis, 18, 207-214 (1997).
34. Smith, C. G. and Asch, R. H., Acute, short-term, and chronic effects of marijuana on the female primate reproductive function. NIDA Res. Monogr., 44, 82-96 (1984).
35. Smith, C. J., Qian, X., Zha, Q., and Moldoveanu, S. C., Analysis of alpha- and beta-carbolines in mainstream smoke of reference cigarettes by gas chromatography-mass spectrometry. J. Chromatogr. A, 1046, 211-216 (2004).
36. Smith, R. G., Besch, N. F., Besch, P. K., and Smith, C. G., Inhibition of gonadotropin by delta9-tetrahydrocannabinol : mediation by steroid receptors? Science, 204, 325-327 (1979).
37. Spangler, J. G., Smoking and hormone-related disorders. Prim. Care, 26, 499-511 (1999).
38. Spink, D. C., Eugster, H. P., Lincoln, D. W. 2nd, Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S., and Gierthy, J. F., 17 Beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293, 342-348 (1992).
39. Suchar, L. A., Chang, R. L., Rosen, R. T., Lech, J., and Conney, A. H., High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. J. Pharmacol. Exp. Ther., 272, 197-206 (1995).
40. Szaefer, H., Jodynis-Liebert, J., Cichocki, M., Matuszewska, A., and Baer-Dubowska, W., Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine. Toxicology, 186, 67-77 (2003).
41. Tanaka, S., Haji, M., Takayanagi, R., Tanaka, S., Sugioka, Y., and Nawata, H., 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology, 137, 1860-1869 (1996).
42. Topinka, J., Schwarz, L. R., Kiefer, F., Wiebel, F. J., Gajdos, O., Vidova, P., Dobias, L., Fried, M., Sram, R. J., and Wolff, T., DNA adduct formation in mammalian cell cultures by polycyclic aromatic hydrocarbons (PAH) and nitro-PAH in coke oven emission extract. Mutat. Res., 419, 91-105 (1998).
43. Tran, D. Q., Ide, C.,F., McLachlan, J. A., and Arnold, S. F., The anti-estrogenic activity of selected polynuclear aromatic hydrocarbons in yeast expressing human estrogen receptor. Biochem. Biophys. Res. Commun., 229, 101-108 (1996).
44. Tsuchiya, Y., Nakajima, M., and Yokoi, T., Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett., 227, 115-124 (2005).
45. Watanabe, K., Motoya, E., Matsuzawa, N., Funahashi, T., Kimura, T., Matsunaga, T., Arizono, K., and Yamamoto, I., Marijuana extracts possess the effects like the endocrine disrupting chemicals. Toxicology, 206, 471-478 (2005).
46. Yamazaki, H., Shaw, P. M., Guengerich, F. P., and Shimada, T., Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem. Res. Toxicol., 11, 659-665 (1998).